Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$72.5 - $100.68 $174,652 - $242,538
-2,409 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$93.66 - $139.27 $45,893 - $68,242
-490 Reduced 16.9%
2,409 $299,000
Q4 2020

Feb 05, 2021

SELL
$99.61 - $142.12 $1,095 - $1,563
-11 Reduced 0.38%
2,899 $384,000
Q3 2020

Nov 13, 2020

SELL
$72.92 - $102.01 $3,208 - $4,488
-44 Reduced 1.49%
2,910 $297,000
Q2 2020

Aug 03, 2020

BUY
$55.75 - $92.75 $164,685 - $273,983
2,954 New
2,954 $257,000
Q3 2019

Nov 12, 2019

SELL
$90.37 - $122.49 $186,342 - $252,574
-2,062 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$89.51 - $118.04 $35,266 - $46,507
-394 Reduced 16.04%
2,062 $243,000
Q1 2019

May 07, 2019

SELL
$61.98 - $96.5 $7.21 Million - $11.2 Million
-116,300 Reduced 97.93%
2,456 $213,000
Q4 2018

Feb 13, 2019

SELL
$56.04 - $82.66 $4.21 Million - $6.22 Million
-75,207 Reduced 38.77%
118,756 $7.49 Million
Q3 2018

Nov 13, 2018

SELL
$48.29 - $80.6 $3.01 Million - $5.02 Million
-62,303 Reduced 24.31%
193,963 $15.3 Million
Q2 2018

Aug 09, 2018

SELL
$37.84 - $69.96 $551,026 - $1.02 Million
-14,562 Reduced 5.38%
256,266 $15.3 Million
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $2.58 Million - $3.72 Million
64,734 Added 31.41%
270,828 $10.9 Million
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $4.47 Million - $5.81 Million
96,043 Added 87.27%
206,094 $10.8 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $4.08 Million - $5.19 Million
110,051
110,051 $5.19 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Redwood Investments, LLC Portfolio

Follow Redwood Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investments, LLC with notifications on news.